Liminatus Pharma, Inc. · NASDAQ:LIMN
KH Feelux Co., Ltd reported a 15.40% stake in Liminatus Pharma, Inc. (Schedule 13G)
Event Apr 30, 2025 · Filed Jun 27, 2025
KH Feelux Co., Ltd reported a 15.40% stake in Liminatus Pharma, Inc., 4,000,000 shares, as a passive investor on Apr 30, 2025. Filed Jun 27, 2025 (Schedule 13G).
- Stake
- 15.40%
- Shares
- 4,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| KH Feelux Co., Ltd | 15.40% | 4,000,000 |
Source
Related
- Liminatus Pharma, Inc.
- KH Feelux Co., Ltd
- Liminatus Pharma, Inc. shareholders
- Schedule 13G · Samda Biolab Co., Ltd. · Jul 22, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 14, 2026
- Schedule 13D/A · Valetudo Therapeutics LLC · Jul 14, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 6, 2026
- Schedule 13G/A · Ewon Comfortech Co., Ltd. · Jul 6, 2026